Yale’s Craig Crews leveraged basic science research that formed the basis of a cancer drug eventually valued at nearly $10 billion.Now Crews, the Lewis B. Cullman Professor of Molecular, Cellular and Developmental Biology and professor of chemistry and...
The Yale Center for Biomedical and Interventional Technology (CBIT) will lead a new $1 million seed grant program over two years from the Connecticut BioScience Innovation Fund to support commercialization of new biomedical ideas from Connecticut...